# CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma

> **NCT03110744** · PHASE2 · COMPLETED · sponsor: **University Hospital Heidelberg** · enrollment: 43 (actual)

## Conditions studied

- Chordoma

## Interventions

- **DRUG:** Palbociclib

## Key facts

- **NCT ID:** NCT03110744
- **Lead sponsor:** University Hospital Heidelberg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-15
- **Primary completion:** 2022-12-22
- **Final completion:** 2022-12-22
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110744, "CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03110744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*